 | • レポートコード：MRC2-11QY03651 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はがん支持療法のグローバル市場について調査・分析したレポートです。種類別（非ステロイド性エリスロポエチン刺激剤、オピオイド鎮痛薬、抗炎症治療薬、抗感染治療薬、ビスホスホネート、制吐薬、モノクローナル抗体、顆粒球コロニー刺激因子）市場規模、用途別（肺がん、乳がん、前立腺がん、肝臓がん、膀胱がん、白血病、卵巣がん、黒色腫、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別がん支持療法の競争状況、市場シェア ・世界のがん支持療法市場：種類別市場規模 2015年-2020年（非ステロイド性エリスロポエチン刺激剤、オピオイド鎮痛薬、抗炎症治療薬、抗感染治療薬、ビスホスホネート、制吐薬、モノクローナル抗体、顆粒球コロニー刺激因子） ・世界のがん支持療法市場：種類別市場規模予測 2021年-2026年（非ステロイド性エリスロポエチン刺激剤、オピオイド鎮痛薬、抗炎症治療薬、抗感染治療薬、ビスホスホネート、制吐薬、モノクローナル抗体、顆粒球コロニー刺激因子） ・世界のがん支持療法市場：用途別市場規模 2015年-2020年（肺がん、乳がん、前立腺がん、肝臓がん、膀胱がん、白血病、卵巣がん、黒色腫、その他） ・世界のがん支持療法市場：用途別市場規模予測 2021年-2026年（肺がん、乳がん、前立腺がん、肝臓がん、膀胱がん、白血病、卵巣がん、黒色腫、その他） ・北米のがん支持療法市場分析：米国、カナダ ・ヨーロッパのがん支持療法市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのがん支持療法市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のがん支持療法市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのがん支持療法市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Amgen、Helsinn Healthcare、Johnson &Johnson、Merck、F. Hoffmann-La Roche、GlaxoSmithKline、Novartis、TESARO、Teva Pharmaceutical Industries ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life.
With growing prevalence of cancer, the demand for cancer treatments, such as chemotherapy has also been consistently on the rise since the past decade. However, radiation therapy brings with it a host of side effects that are challenging for cancer patients to face while they undergo the course of treatment. While the cancer treatment realm is tremendously progressing, the incidences of side effects are increasing as well, which are addressed by cancer supportive care. The advent of technology in cancer supportive care has enabled to treat different signs and symptoms following the chemotherapy procedure, in addition to chemotherapy-induced vomiting, nausea, neutropenia, and anemia. The global market for cancer supportive care products is currently thriving at a sound pace and is anticipated to see steady growth over the next few years.
Market Analysis and Insights: Global Cancer Supportive Care Market
The global Cancer Supportive Care market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cancer Supportive Care Scope and Market Size
Cancer Supportive Care market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Supportive Care market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Cancer Supportive Care market is segmented into
Nonsteroidal Erythropoietin Stimulating Agents
Opioid Analgesics
Anti-Imflammatory Drugs
Anti-Infective Drugs
Bisphosphonates
Anti-Emetics Drugs
Monoclonal Antibodies
Granulocyte Colony Stimulating Factor
Segment by Application, the Cancer Supportive Care market is segmented into
Lung Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Bladder Cancer
Leukemia
Ovarian Cancer
Melanoma
Others
Regional and Country-level Analysis
The Cancer Supportive Care market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cancer Supportive Care market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cancer Supportive Care Market Share Analysis
Cancer Supportive Care market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Supportive Care business, the date to enter into the Cancer Supportive Care market, Cancer Supportive Care product introduction, recent developments, etc.
The major vendors covered:
Amgen
Helsinn Healthcare
Johnson &Johnson
Merck
F. Hoffmann-La Roche
GlaxoSmithKline
Novartis
TESARO
Teva Pharmaceutical Industries
1 Study Coverage
1.1 Cancer Supportive Care Product Introduction
1.2 Market Segments
1.3 Key Cancer Supportive Care Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cancer Supportive Care Market Size Growth Rate by Type
1.4.2 Nonsteroidal Erythropoietin Stimulating Agents
1.4.3 Opioid Analgesics
1.4.4 Anti-Imflammatory Drugs
1.4.5 Anti-Infective Drugs
1.4.6 Bisphosphonates
1.4.7 Anti-Emetics Drugs
1.4.8 Monoclonal Antibodies
1.4.9 Granulocyte Colony Stimulating Factor
1.5 Market by Application
1.5.1 Global Cancer Supportive Care Market Size Growth Rate by Application
1.5.2 Lung Cancer
1.5.3 Breast Cancer
1.5.4 Prostate Cancer
1.5.5 Liver Cancer
1.5.6 Bladder Cancer
1.5.7 Leukemia
1.5.8 Ovarian Cancer
1.5.9 Melanoma
1.5.10 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cancer Supportive Care Market Size, Estimates and Forecasts
2.1.1 Global Cancer Supportive Care Revenue 2015-2026
2.1.2 Global Cancer Supportive Care Sales 2015-2026
2.2 Global Cancer Supportive Care, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Cancer Supportive Care Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Cancer Supportive Care Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Cancer Supportive Care Competitor Landscape by Players
3.1 Cancer Supportive Care Sales by Manufacturers
3.1.1 Cancer Supportive Care Sales by Manufacturers (2015-2020)
3.1.2 Cancer Supportive Care Sales Market Share by Manufacturers (2015-2020)
3.2 Cancer Supportive Care Revenue by Manufacturers
3.2.1 Cancer Supportive Care Revenue by Manufacturers (2015-2020)
3.2.2 Cancer Supportive Care Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cancer Supportive Care Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cancer Supportive Care Revenue in 2019
3.2.5 Global Cancer Supportive Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Cancer Supportive Care Price by Manufacturers
3.4 Cancer Supportive Care Manufacturing Base Distribution, Product Types
3.4.1 Cancer Supportive Care Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Supportive Care Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Supportive Care Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cancer Supportive Care Market Size by Type (2015-2020)
4.1.1 Global Cancer Supportive Care Sales by Type (2015-2020)
4.1.2 Global Cancer Supportive Care Revenue by Type (2015-2020)
4.1.3 Cancer Supportive Care Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cancer Supportive Care Market Size Forecast by Type (2021-2026)
4.2.1 Global Cancer Supportive Care Sales Forecast by Type (2021-2026)
4.2.2 Global Cancer Supportive Care Revenue Forecast by Type (2021-2026)
4.2.3 Cancer Supportive Care Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cancer Supportive Care Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cancer Supportive Care Market Size by Application (2015-2020)
5.1.1 Global Cancer Supportive Care Sales by Application (2015-2020)
5.1.2 Global Cancer Supportive Care Revenue by Application (2015-2020)
5.1.3 Cancer Supportive Care Price by Application (2015-2020)
5.2 Cancer Supportive Care Market Size Forecast by Application (2021-2026)
5.2.1 Global Cancer Supportive Care Sales Forecast by Application (2021-2026)
5.2.2 Global Cancer Supportive Care Revenue Forecast by Application (2021-2026)
5.2.3 Global Cancer Supportive Care Price Forecast by Application (2021-2026)
6 North America
6.1 North America Cancer Supportive Care by Country
6.1.1 North America Cancer Supportive Care Sales by Country
6.1.2 North America Cancer Supportive Care Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Cancer Supportive Care Market Facts & Figures by Type
6.3 North America Cancer Supportive Care Market Facts & Figures by Application
7 Europe
7.1 Europe Cancer Supportive Care by Country
7.1.1 Europe Cancer Supportive Care Sales by Country
7.1.2 Europe Cancer Supportive Care Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cancer Supportive Care Market Facts & Figures by Type
7.3 Europe Cancer Supportive Care Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Cancer Supportive Care by Region
8.1.1 Asia Pacific Cancer Supportive Care Sales by Region
8.1.2 Asia Pacific Cancer Supportive Care Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Cancer Supportive Care Market Facts & Figures by Type
8.3 Asia Pacific Cancer Supportive Care Market Facts & Figures by Application
9 Latin America
9.1 Latin America Cancer Supportive Care by Country
9.1.1 Latin America Cancer Supportive Care Sales by Country
9.1.2 Latin America Cancer Supportive Care Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Cancer Supportive Care Market Facts & Figures by Type
9.3 Central & South America Cancer Supportive Care Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Cancer Supportive Care by Country
10.1.1 Middle East and Africa Cancer Supportive Care Sales by Country
10.1.2 Middle East and Africa Cancer Supportive Care Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Cancer Supportive Care Market Facts & Figures by Type
10.3 Middle East and Africa Cancer Supportive Care Market Facts & Figures by Application
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description and Business Overview
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Cancer Supportive Care Products Offered
11.1.5 Amgen Related Developments
11.2 Helsinn Healthcare
11.2.1 Helsinn Healthcare Corporation Information
11.2.2 Helsinn Healthcare Description and Business Overview
11.2.3 Helsinn Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Helsinn Healthcare Cancer Supportive Care Products Offered
11.2.5 Helsinn Healthcare Related Developments
11.3 Johnson &Johnson
11.3.1 Johnson &Johnson Corporation Information
11.3.2 Johnson &Johnson Description and Business Overview
11.3.3 Johnson &Johnson Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson &Johnson Cancer Supportive Care Products Offered
11.3.5 Johnson &Johnson Related Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description and Business Overview
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Cancer Supportive Care Products Offered
11.4.5 Merck Related Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Corporation Information
11.5.2 F. Hoffmann-La Roche Description and Business Overview
11.5.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.5.4 F. Hoffmann-La Roche Cancer Supportive Care Products Offered
11.5.5 F. Hoffmann-La Roche Related Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Description and Business Overview
11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline Cancer Supportive Care Products Offered
11.6.5 GlaxoSmithKline Related Developments
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Description and Business Overview
11.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novartis Cancer Supportive Care Products Offered
11.7.5 Novartis Related Developments
11.8 TESARO
11.8.1 TESARO Corporation Information
11.8.2 TESARO Description and Business Overview
11.8.3 TESARO Sales, Revenue and Gross Margin (2015-2020)
11.8.4 TESARO Cancer Supportive Care Products Offered
11.8.5 TESARO Related Developments
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Corporation Information
11.9.2 Teva Pharmaceutical Industries Description and Business Overview
11.9.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Teva Pharmaceutical Industries Cancer Supportive Care Products Offered
11.9.5 Teva Pharmaceutical Industries Related Developments
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description and Business Overview
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Cancer Supportive Care Products Offered
11.1.5 Amgen Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Cancer Supportive Care Market Estimates and Projections by Region
12.1.1 Global Cancer Supportive Care Sales Forecast by Regions 2021-2026
12.1.2 Global Cancer Supportive Care Revenue Forecast by Regions 2021-2026
12.2 North America Cancer Supportive Care Market Size Forecast (2021-2026)
12.2.1 North America: Cancer Supportive Care Sales Forecast (2021-2026)
12.2.2 North America: Cancer Supportive Care Revenue Forecast (2021-2026)
12.2.3 North America: Cancer Supportive Care Market Size Forecast by Country (2021-2026)
12.3 Europe Cancer Supportive Care Market Size Forecast (2021-2026)
12.3.1 Europe: Cancer Supportive Care Sales Forecast (2021-2026)
12.3.2 Europe: Cancer Supportive Care Revenue Forecast (2021-2026)
12.3.3 Europe: Cancer Supportive Care Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Cancer Supportive Care Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Cancer Supportive Care Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Cancer Supportive Care Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Cancer Supportive Care Market Size Forecast by Region (2021-2026)
12.5 Latin America Cancer Supportive Care Market Size Forecast (2021-2026)
12.5.1 Latin America: Cancer Supportive Care Sales Forecast (2021-2026)
12.5.2 Latin America: Cancer Supportive Care Revenue Forecast (2021-2026)
12.5.3 Latin America: Cancer Supportive Care Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Cancer Supportive Care Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Cancer Supportive Care Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Cancer Supportive Care Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Cancer Supportive Care Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Cancer Supportive Care Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Supportive Care Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Cancer Supportive Care Market Segments
Table 2. Ranking of Global Top Cancer Supportive Care Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cancer Supportive Care Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Nonsteroidal Erythropoietin Stimulating Agents
Table 5. Major Manufacturers of Opioid Analgesics
Table 6. Major Manufacturers of Anti-Imflammatory Drugs
Table 7. Major Manufacturers of Anti-Infective Drugs
Table 8. Major Manufacturers of Bisphosphonates
Table 9. Major Manufacturers of Anti-Emetics Drugs
Table 10. Major Manufacturers of Monoclonal Antibodies
Table 11. Major Manufacturers of Granulocyte Colony Stimulating Factor
Table 12. Global Cancer Supportive Care Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Cancer Supportive Care Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Cancer Supportive Care Sales by Regions 2015-2020 (K Units)
Table 15. Global Cancer Supportive Care Sales Market Share by Regions (2015-2020)
Table 16. Global Cancer Supportive Care Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Cancer Supportive Care Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Cancer Supportive Care Sales Share by Manufacturers (2015-2020)
Table 19. Global Cancer Supportive Care Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Cancer Supportive Care by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Supportive Care as of 2019)
Table 21. Cancer Supportive Care Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Cancer Supportive Care Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Cancer Supportive Care Price (2015-2020) (USD/Unit)
Table 24. Cancer Supportive Care Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Cancer Supportive Care Product Type
Table 26. Date of International Manufacturers Enter into Cancer Supportive Care Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Cancer Supportive Care Sales by Type (2015-2020) (K Units)
Table 29. Global Cancer Supportive Care Sales Share by Type (2015-2020)
Table 30. Global Cancer Supportive Care Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Cancer Supportive Care Revenue Share by Type (2015-2020)
Table 32. Cancer Supportive Care Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Cancer Supportive Care Sales by Application (2015-2020) (K Units)
Table 34. Global Cancer Supportive Care Sales Share by Application (2015-2020)
Table 35. North America Cancer Supportive Care Sales by Country (2015-2020) (K Units)
Table 36. North America Cancer Supportive Care Sales Market Share by Country (2015-2020)
Table 37. North America Cancer Supportive Care Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Cancer Supportive Care Revenue Market Share by Country (2015-2020)
Table 39. North America Cancer Supportive Care Sales by Type (2015-2020) (K Units)
Table 40. North America Cancer Supportive Care Sales Market Share by Type (2015-2020)
Table 41. North America Cancer Supportive Care Sales by Application (2015-2020) (K Units)
Table 42. North America Cancer Supportive Care Sales Market Share by Application (2015-2020)
Table 43. Europe Cancer Supportive Care Sales by Country (2015-2020) (K Units)
Table 44. Europe Cancer Supportive Care Sales Market Share by Country (2015-2020)
Table 45. Europe Cancer Supportive Care Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Cancer Supportive Care Revenue Market Share by Country (2015-2020)
Table 47. Europe Cancer Supportive Care Sales by Type (2015-2020) (K Units)
Table 48. Europe Cancer Supportive Care Sales Market Share by Type (2015-2020)
Table 49. Europe Cancer Supportive Care Sales by Application (2015-2020) (K Units)
Table 50. Europe Cancer Supportive Care Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Cancer Supportive Care Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Cancer Supportive Care Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Cancer Supportive Care Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Cancer Supportive Care Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Cancer Supportive Care Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Cancer Supportive Care Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Cancer Supportive Care Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Cancer Supportive Care Sales Market Share by Application (2015-2020)
Table 59. Latin America Cancer Supportive Care Sales by Country (2015-2020) (K Units)
Table 60. Latin America Cancer Supportive Care Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Cancer Supportive Care Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Cancer Supportive Care Revenue Market Share by Country (2015-2020)
Table 63. Latin America Cancer Supportive Care Sales by Type (2015-2020) (K Units)
Table 64. Latin America Cancer Supportive Care Sales Market Share by Type (2015-2020)
Table 65. Latin America Cancer Supportive Care Sales by Application (2015-2020) (K Units)
Table 66. Latin America Cancer Supportive Care Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Cancer Supportive Care Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Cancer Supportive Care Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Cancer Supportive Care Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Cancer Supportive Care Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Cancer Supportive Care Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Cancer Supportive Care Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Cancer Supportive Care Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Cancer Supportive Care Sales Market Share by Application (2015-2020)
Table 75. Amgen Corporation Information
Table 76. Amgen Description and Major Businesses
Table 77. Amgen Cancer Supportive Care Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Amgen Product
Table 79. Amgen Recent Development
Table 80. Helsinn Healthcare Corporation Information
Table 81. Helsinn Healthcare Description and Major Businesses
Table 82. Helsinn Healthcare Cancer Supportive Care Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Helsinn Healthcare Product
Table 84. Helsinn Healthcare Recent Development
Table 85. Johnson &Johnson Corporation Information
Table 86. Johnson &Johnson Description and Major Businesses
Table 87. Johnson &Johnson Cancer Supportive Care Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Johnson &Johnson Product
Table 89. Johnson &Johnson Recent Development
Table 90. Merck Corporation Information
Table 91. Merck Description and Major Businesses
Table 92. Merck Cancer Supportive Care Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Merck Product
Table 94. Merck Recent Development
Table 95. F. Hoffmann-La Roche Corporation Information
Table 96. F. Hoffmann-La Roche Description and Major Businesses
Table 97. F. Hoffmann-La Roche Cancer Supportive Care Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. F. Hoffmann-La Roche Product
Table 99. F. Hoffmann-La Roche Recent Development
Table 100. GlaxoSmithKline Corporation Information
Table 101. GlaxoSmithKline Description and Major Businesses
Table 102. GlaxoSmithKline Cancer Supportive Care Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. GlaxoSmithKline Product
Table 104. GlaxoSmithKline Recent Development
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Major Businesses
Table 107. Novartis Cancer Supportive Care Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Novartis Product
Table 109. Novartis Recent Development
Table 110. TESARO Corporation Information
Table 111. TESARO Description and Major Businesses
Table 112. TESARO Cancer Supportive Care Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. TESARO Product
Table 114. TESARO Recent Development
Table 115. Teva Pharmaceutical Industries Corporation Information
Table 116. Teva Pharmaceutical Industries Description and Major Businesses
Table 117. Teva Pharmaceutical Industries Cancer Supportive Care Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Teva Pharmaceutical Industries Product
Table 119. Teva Pharmaceutical Industries Recent Development
Table 120. Global Cancer Supportive Care Sales Forecast by Regions (2021-2026) (K Units)
Table 121. Global Cancer Supportive Care Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global Cancer Supportive Care Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global Cancer Supportive Care Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: Cancer Supportive Care Sales Forecast by Country (2021-2026) (K Units)
Table 125. North America: Cancer Supportive Care Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: Cancer Supportive Care Sales Forecast by Country (2021-2026) (K Units)
Table 127. Europe: Cancer Supportive Care Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: Cancer Supportive Care Sales Forecast by Region (2021-2026) (K Units)
Table 129. Asia Pacific: Cancer Supportive Care Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: Cancer Supportive Care Sales Forecast by Country (2021-2026) (K Units)
Table 131. Latin America: Cancer Supportive Care Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: Cancer Supportive Care Sales Forecast by Country (2021-2026) (K Units)
Table 133. Middle East and Africa: Cancer Supportive Care Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Cancer Supportive Care Players
Table 138. Cancer Supportive Care Customers List
Table 139. Cancer Supportive Care Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Supportive Care Product Picture
Figure 2. Global Cancer Supportive Care Sales Market Share by Type in 2020 & 2026
Figure 3. Nonsteroidal Erythropoietin Stimulating Agents Product Picture
Figure 4. Opioid Analgesics Product Picture
Figure 5. Anti-Imflammatory Drugs Product Picture
Figure 6. Anti-Infective Drugs Product Picture
Figure 7. Bisphosphonates Product Picture
Figure 8. Anti-Emetics Drugs Product Picture
Figure 9. Monoclonal Antibodies Product Picture
Figure 10. Granulocyte Colony Stimulating Factor Product Picture
Figure 11. Global Cancer Supportive Care Sales Market Share by Application in 2020 & 2026
Figure 12. Lung Cancer
Figure 13. Breast Cancer
Figure 14. Prostate Cancer
Figure 15. Liver Cancer
Figure 16. Bladder Cancer
Figure 17. Leukemia
Figure 18. Ovarian Cancer
Figure 19. Melanoma
Figure 20. Others
Figure 21. Cancer Supportive Care Report Years Considered
Figure 22. Global Cancer Supportive Care Market Size 2015-2026 (US$ Million)
Figure 23. Global Cancer Supportive Care Sales 2015-2026 (K Units)
Figure 24. Global Cancer Supportive Care Market Size Market Share by Region: 2020 Versus 2026
Figure 25. Global Cancer Supportive Care Sales Market Share by Region (2015-2020)
Figure 26. Global Cancer Supportive Care Sales Market Share by Region in 2019
Figure 27. Global Cancer Supportive Care Revenue Market Share by Region (2015-2020)
Figure 28. Global Cancer Supportive Care Revenue Market Share by Region in 2019
Figure 29. Global Cancer Supportive Care Sales Share by Manufacturer in 2019
Figure 30. The Top 10 and 5 Players Market Share by Cancer Supportive Care Revenue in 2019
Figure 31. Cancer Supportive Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 32. Global Cancer Supportive Care Sales Market Share by Type (2015-2020)
Figure 33. Global Cancer Supportive Care Sales Market Share by Type in 2019
Figure 34. Global Cancer Supportive Care Revenue Market Share by Type (2015-2020)
Figure 35. Global Cancer Supportive Care Revenue Market Share by Type in 2019
Figure 36. Global Cancer Supportive Care Market Share by Price Range (2015-2020)
Figure 37. Global Cancer Supportive Care Sales Market Share by Application (2015-2020)
Figure 38. Global Cancer Supportive Care Sales Market Share by Application in 2019
Figure 39. Global Cancer Supportive Care Revenue Market Share by Application (2015-2020)
Figure 40. Global Cancer Supportive Care Revenue Market Share by Application in 2019
Figure 41. North America Cancer Supportive Care Sales Growth Rate 2015-2020 (K Units)
Figure 42. North America Cancer Supportive Care Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America Cancer Supportive Care Sales Market Share by Country in 2019
Figure 44. North America Cancer Supportive Care Revenue Market Share by Country in 2019
Figure 45. U.S. Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 46. U.S. Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 48. Canada Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. North America Cancer Supportive Care Market Share by Type in 2019
Figure 50. North America Cancer Supportive Care Market Share by Application in 2019
Figure 51. Europe Cancer Supportive Care Sales Growth Rate 2015-2020 (K Units)
Figure 52. Europe Cancer Supportive Care Revenue Growth Rate 2015-2020 (US$ Million)
Figure 53. Europe Cancer Supportive Care Sales Market Share by Country in 2019
Figure 54. Europe Cancer Supportive Care Revenue Market Share by Country in 2019
Figure 55. Germany Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 56. Germany Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. France Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 58. France Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. U.K. Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 60. U.K. Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Italy Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 62. Italy Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Russia Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 64. Russia Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Europe Cancer Supportive Care Market Share by Type in 2019
Figure 66. Europe Cancer Supportive Care Market Share by Application in 2019
Figure 67. Asia Pacific Cancer Supportive Care Sales Growth Rate 2015-2020 (K Units)
Figure 68. Asia Pacific Cancer Supportive Care Revenue Growth Rate 2015-2020 (US$ Million)
Figure 69. Asia Pacific Cancer Supportive Care Sales Market Share by Region in 2019
Figure 70. Asia Pacific Cancer Supportive Care Revenue Market Share by Region in 2019
Figure 71. China Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 72. China Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Japan Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 74. Japan Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. South Korea Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 76. South Korea Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. India Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 78. India Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Australia Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 80. Australia Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Taiwan Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 82. Taiwan Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Indonesia Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 84. Indonesia Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Thailand Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 86. Thailand Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Malaysia Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 88. Malaysia Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Philippines Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 90. Philippines Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Vietnam Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 92. Vietnam Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Asia Pacific Cancer Supportive Care Market Share by Type in 2019
Figure 94. Asia Pacific Cancer Supportive Care Market Share by Application in 2019
Figure 95. Latin America Cancer Supportive Care Sales Growth Rate 2015-2020 (K Units)
Figure 96. Latin America Cancer Supportive Care Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Latin America Cancer Supportive Care Sales Market Share by Country in 2019
Figure 98. Latin America Cancer Supportive Care Revenue Market Share by Country in 2019
Figure 99. Mexico Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 100. Mexico Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Brazil Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 102. Brazil Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Argentina Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 104. Argentina Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Latin America Cancer Supportive Care Market Share by Type in 2019
Figure 106. Latin America Cancer Supportive Care Market Share by Application in 2019
Figure 107. Middle East and Africa Cancer Supportive Care Sales Growth Rate 2015-2020 (K Units)
Figure 108. Middle East and Africa Cancer Supportive Care Revenue Growth Rate 2015-2020 (US$ Million)
Figure 109. Middle East and Africa Cancer Supportive Care Sales Market Share by Country in 2019
Figure 110. Middle East and Africa Cancer Supportive Care Revenue Market Share by Country in 2019
Figure 111. Turkey Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 112. Turkey Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 113. Saudi Arabia Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 114. Saudi Arabia Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 115. U.A.E Cancer Supportive Care Sales Growth Rate (2015-2020) (K Units)
Figure 116. U.A.E Cancer Supportive Care Revenue Growth Rate (2015-2020) (US$ Million)
Figure 117. Middle East and Africa Cancer Supportive Care Market Share by Type in 2019
Figure 118. Middle East and Africa Cancer Supportive Care Market Share by Application in 2019
Figure 119. North America Cancer Supportive Care Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. North America Cancer Supportive Care Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Cancer Supportive Care Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Europe Cancer Supportive Care Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Cancer Supportive Care Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Asia Pacific Cancer Supportive Care Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Cancer Supportive Care Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. Latin America Cancer Supportive Care Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Cancer Supportive Care Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 128. Middle East and Africa Cancer Supportive Care Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed
癌支持療法薬の世界市場（～2026年） Market Analysis and Insights: Global Cancer Supportive Care Medicine Market The global Cancer Supportive Care Medicine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Supportive Care Medicine Scope and Market Si…- 顆粒球マクロファージコロニー刺激因子の世界市場（～2026年） Market Analysis and Insights: Global Granulocyte Macrophage Colony Stimulating Factor Market The global Granulocyte Macrophage Colony Stimulating Factor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Granulocyte Macro…
- 非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…
- 抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…